2000
DOI: 10.2116/analsci.16.31
|View full text |Cite
|
Sign up to set email alerts
|

Production and Characterization of Monoclonal Antibodies Recognizing the Asymmetric Center of Optically Active Bufuralol and Its Metabolites

Abstract: The chromatographic determination of enantiomeric drugs and the metabolites in biological fluids is one of the most important subjects in biomedical analysis, because the individual isomers exhibit different pharmacological properties as well as pharmacokinetic and metabolic fates.Bufuralol, 1-(7-ethylbenzofuran-2-yl)-2-t-butylamino-1-hydroxyethane, is a nonselective β-adrenergic receptor antagonist 1 with partial β2-agonist properties 2,3 and is administered as the racemic form. The β-blocking potency of (1S)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2005
2005

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…The immunosorbent we have described may also be applied to the group extraction of (S)-enantiomers of ibuprofen and its metabolites such as taurine conjugate and acyl glucuronide from biological fluids prior to the chromatographic determination of target compounds. In a previous paper, we disclosed the utility of a monoclonal antibody for the immunohistochemical extraction of optical active bufuralol and its metabolites (33). Production of a monoclonal antibody utilizing the same immunogenic conjugate is our next end.…”
Section: Figmentioning
confidence: 99%
“…The immunosorbent we have described may also be applied to the group extraction of (S)-enantiomers of ibuprofen and its metabolites such as taurine conjugate and acyl glucuronide from biological fluids prior to the chromatographic determination of target compounds. In a previous paper, we disclosed the utility of a monoclonal antibody for the immunohistochemical extraction of optical active bufuralol and its metabolites (33). Production of a monoclonal antibody utilizing the same immunogenic conjugate is our next end.…”
Section: Figmentioning
confidence: 99%